The EDC Consolidation Play That Could Actually Fix Your Query Backlog
CRScube acquired Mednet in Nov 2025, uniting 84,000 site users under one AI-assisted EDC. Here's what that means for...
Site Operations
Your IP Is Sitting in a Freezer Somewhere, And Your CRA Doesn’t Know Where
Decentralized supply management is breaking traditional cold-chain oversight. Here's what DSM failures cost sites in enrollment ramp and budget...
Enrollment Closed: What Moleculin’s MIRACLE Trial Teaches About AML Site Execution
Moleculin closed Part A enrollment at 89 subjects in its pivotal AML MIRACLE trial. Here's what site directors and...
When the Primary Endpoint Moves After 283 Patients Are Already In
A mid-trial primary outcome amendment in a thrombectomy study reveals the operational chain reaction sites and sponsor clinops teams...
The 90% Automation Promise Means Nothing to a Coordinator Running 12 Systems
Medable's CEO wants 90% of clinical trials automated by 2030. Site coordinators are still manually bridging 12 disconnected systems....
When Your CRO Gets Acquired Mid-Study, Your Site Feels It First
Curavit's acquisition of Lindus Health's CRO assets unifies 13,478 sites across 79 countries — but site teams will navigate...
The 82x ROI Claim Looks Great on a Slide Deck — But Who’s Paying for the Infrastructure at the Site?
Tufts CSDD says AI monitoring agents deliver 82x ROI in Phase 3 oncology. But that number assumes sites can...
When Your CRO’s AI Sends a Query, Who’s Accountable for the Answer?
ICON's Anthropic partnership deploys Claude into clinical trial monitoring. Here's what site coordinators and ops leads need to verify...
What ICON’s Claude Deal Actually Means for the Site Coordinator Running Your Trial
ICON's Anthropic partnership deploys Claude AI into clinical trials. Here's what it means for EDC workflows, IRB docs, and...
Your Biometrics Vendor Is Not Built for What Your Next Trial Requires
Acrosian's AI-native CRO launch forces a real question: can legacy biometrics vendors support DCT-era data demands, or is your...